Aberdeen Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-229,078
| Closed | -$19.1M | – | 972 |
|
|
2024
Q4 | $19.1M | Sell |
229,078
-21,885
| -9% | -$1.83M | 0.04% | 379 |
|
|
2024
Q3 | $18.4M | Buy |
250,963
+17,612
| +8% | +$1.29M | 0.03% | 405 |
|
|
2024
Q2 | $16M | Buy |
233,351
+99,529
| +74% | +$6.82M | 0.03% | 425 |
|
|
2024
Q1 | $9.26M | Buy |
133,822
+75,127
| +128% | +$5.2M | 0.02% | 567 |
|
|
2023
Q4 | $4.2M | Buy |
+58,695
| New | +$4.2M | 0.01% | 698 |
|